OSX — Osteopore Income Statement
0.000.00%
Last trade - 00:00
- AU$45.45m
- AU$45.42m
- AU$2.22m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.412 | 1.5 | 1.11 | 1.69 | 2.22 |
Cost of Revenue | |||||
Gross Profit | 0.288 | 0.955 | 0.812 | 1.27 | 1.64 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.78 | 3.43 | 4.72 | 5.87 | 7.03 |
Operating Profit | -2.37 | -1.93 | -3.6 | -4.17 | -4.81 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.38 | -1.95 | -3.62 | -4.2 | -4.83 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.38 | -1.95 | -3.62 | -4.2 | -4.87 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.38 | -1.95 | -3.62 | -4.2 | -4.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.38 | -1.95 | -3.62 | -4.2 | -4.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.046 | -0.048 | -0.082 | -0.09 | -0.091 |